Epithalon vs Tirzepatide
Overview
Epithalon is primarily a sleep & recovery peptide, while Tirzepatide is used for weight management & metabolic.
This page compares Epithalon and Tirzepatide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Epithalon | Tirzepatide | |
|---|---|---|
| Category | Sleep & Recovery | Weight Management & Metabolic |
| Regulatory status (US) | Compounding (Rx) — Apr 2026 | FDA approved |
| Typical dosage | 5-10 mg | 2.5-15 mg |
| Frequency | cycle protocol | weekly |
| Reported benefits | Improved sleep quality, circadian rhythm regulation, anti-aging | Enhanced weight loss, improved insulin sensitivity, better glycemic control, cardiovascular benefits |
| Reported side effects | Minimal side effects during cycles | Similar to semaglutide: GI disturbances, nausea, potential pancreatitis |
Key differences
Primary use. Epithalon is categorised under Sleep & Recovery, while Tirzepatide falls under Weight Management & Metabolic. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Epithalon: not FDA-approved; compounding permitted with a prescription as of April 2026. Tirzepatide: FDA-approved.
Dosing. Epithalon is typically dosed at 5-10 mg (cycle protocol). Tirzepatide is typically dosed at 2.5-15 mg (weekly).
Can you stack them?
Some protocols combine peptides, but stacking Epithalon and Tirzepatide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Epithalon and Tirzepatide?
- Epithalon is primarily a sleep & recovery peptide, while Tirzepatide is used for weight management & metabolic. Epithalon is not FDA-approved; compounding permitted with a prescription (as of April 2026), whereas Tirzepatide is FDA-approved for one or more indications.
- What is Epithalon used for?
- Circadian rhythm regulator.
- What is Tirzepatide used for?
- Dual GIP/GLP-1 agonist for weight loss.
- Can you take Epithalon and Tirzepatide together?
- Some users combine peptides within a single protocol, but stacking Epithalon and Tirzepatide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Epithalon or Tirzepatide FDA-approved?
- Epithalon is not FDA-approved; compounding permitted with a prescription (as of April 2026). Tirzepatide is FDA-approved for one or more indications.
Read the full articles
- Epithalon — full monograph: mechanism, research, dosing & references
- Tirzepatide — full monograph: mechanism, research, dosing & references